about
Evaluation of protein biomarkers of prostate cancer aggressivenessUpregulation of HYAL1 expression in breast cancer promoted tumor cell proliferation, migration, invasion and angiogenesisEpigenetic regulation of HYAL-1 hyaluronidase expression. identification of HYAL-1 promoterThe Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in CancerHyaluronan - a functional and structural sweet spot in the tissue microenvironmentElevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumorsUdp-glucose dehydrogenase as a novel field-specific candidate biomarker of prostate cancerControlled Immobilization Strategies to Probe Short Hyaluronan-Protein Interactions.HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer.Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcomeAssociation of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosisPronounced cancer resistance in a subterranean rodent, the blind mole-rat, Spalax: in vivo and in vitro evidence.TIAF1 self-aggregation in peritumor capsule formation, spontaneous activation of SMAD-responsive promoter in p53-deficient environment, and cell deathDietary supplement 4-methylumbelliferone: an effective chemopreventive and therapeutic agent for prostate cancer.Dietary flavonoid fisetin increases abundance of high-molecular-mass hyaluronan conferring resistance to prostate oncogenesis.Hyaluronan in aged collagen matrix increases prostate epithelial cell proliferation.Signaling from membrane receptors to tumor suppressor WW domain-containing oxidoreductase.Hyaluronan metabolism in remodeling extracellular matrix: probes for imaging and therapy of breast cancer.CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma.Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer.Therapeutic targeting of hyaluronan in the tumor stroma.Targeting hyaluronic acid family for cancer chemoprevention and therapy.Sugars in the microenvironment: the sticky problem of HA turnover in tumors.Opposing effects of high- and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44Cancer microenvironment and inflammation: role of hyaluronan.Carcinoma Cell Hyaluronan as a "Portable" Cancerized Prometastatic Microenvironment.The 2016 John J. Abel Award Lecture: Targeting the Mechanical Microenvironment in Cancer.Accumulation of small hyaluronan oligosaccharides in tumour interstitial fluid correlates with lymphatic invasion and lymph node metastasis.Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence.Targeting hyaluronidase for cancer therapy: antitumor activity of sulfated hyaluronic acid in prostate cancer cells.Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells.Hyaluronan-CD44 Interactions in Cancer: Paradoxes and PossibilitiesHyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression.
P2860
Q21261257-AF17EDF1-A2A4-46FF-9630-6135D3206046Q24321280-79B8E543-D258-422B-8CCD-2A3935406FB6Q24329200-35F75B2B-175A-4E15-AAFB-5F491C5BD1D9Q26747319-A0639A9E-9B4D-48FE-B8E3-4A94C9438087Q28081088-34FE3817-79D6-4896-997E-E7CCB2C0CE7AQ28236788-1DBBA2A6-80C4-4DA3-ADA0-2E455E6D8E2CQ28392741-FA5FE6FC-EA61-413E-A517-86485EA77F8DQ30390394-C8488046-6CBD-4447-A5EF-D3C992B076EAQ33688043-3C405339-5385-4720-AC75-D8F8E2A1981EQ34028208-0286174C-8F21-44C5-AB48-F4754971EB5CQ34512129-37F0BAA3-7CB7-4507-8FC9-8F14B6D46A96Q34929340-E448F8DF-0FF5-4352-A81A-EE8397B91EBDQ35979294-9BC10F0B-0C7D-4FAD-966E-CEDAA5C820BFQ36009814-46EBF034-25AE-4643-941C-C6EF35FC1D0CQ36059412-96AC9380-C644-4F20-B139-D746AE779C99Q36064013-53E00206-07F0-4484-90D7-A7668D56D97BQ37764617-124A3B29-28EE-4114-9403-73C4B93224E0Q37832163-E4CDBCC9-A9E2-4771-B908-E1996D076241Q37946449-22A269D6-DA12-47C5-97CC-533E1A24BCA7Q38149106-4B3FA087-B96C-4C1B-BCBE-7187C0CE9E39Q38161392-DEA44A34-8156-478D-9024-33638C947B2DQ38235792-4B026C2E-A2CF-4AC3-9B26-CC5F8E25CA15Q38260975-16DA33D0-BF4E-42E1-8DE9-176BBD66679AQ38312173-40AADD49-2E21-4158-A181-C0216CECAA61Q38450763-5E4E0C30-C238-4E93-A222-DF8F83934FFDQ38838567-3D293CA6-5BE3-45AF-8F1B-FA0C98D30822Q38981265-217E802A-9903-4E0D-8C34-38414E82B764Q38983885-51613315-D881-4D5D-B56E-F39C77662AB3Q39254195-A39FCD57-1929-4FE7-A269-C967AE6E1D9AQ39545737-2BCABDB3-9E9B-4E38-9D80-16F8F3D2860DQ39723976-BB9AB616-C8AA-4F0B-A011-F03E4A3DEF35Q39919533-89151C82-6BEB-4293-9882-0476D9F4F69FQ55065517-D8125B78-D924-4489-B665-E24131A76EEB
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hyaluronan and hyaluronidase in genitourinary tumors.
@en
Hyaluronan and hyaluronidase in genitourinary tumors.
@nl
type
label
Hyaluronan and hyaluronidase in genitourinary tumors.
@en
Hyaluronan and hyaluronidase in genitourinary tumors.
@nl
prefLabel
Hyaluronan and hyaluronidase in genitourinary tumors.
@en
Hyaluronan and hyaluronidase in genitourinary tumors.
@nl
P2860
P356
P1476
Hyaluronan and hyaluronidase in genitourinary tumors.
@en
P2093
Melanie A Simpson
Vinata B Lokeshwar
P2860
P304
P356
10.2741/3108
P577
2008-05-01T00:00:00Z